Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ES-481 in Adult Patients With Essential Tremors
NCT05234762Phase 2Unknown
- Sponsor
- ES Therapeutics LLC
- Start
- Nov 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of es-481 in essential tremor (ET) (2 arms), sponsored by ES Therapeutics LLC. Primary endpoints: Performance Subscale of The Essential Tremor Rating Assessment Scale at Day 72, Number of participants with abnormal laboratory test results and 3 more. Status: unknown.
02
Drugs
es-481
03
Conditions
essential tremor (ET)
Beyond the preview
Go deeper on NCT05234762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05234762.